Lifeng Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lifeng Ma has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Chen Huang
Department of Gastrointestinal Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
1 shared publication - Dongning Rao
Department of Hepatobiliary Surgery and Transplantation, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion of Ministry of Education, Shanghai, 200032, China
1 shared publication - Guohe Song
Department of Liver Surgery and Transplantation, and Key Laboratory of Carcinogenesis and Cancer Invasion (Ministry of Education), Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, China
1 shared publication - Guoji Guo
Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China
1 shared publication - Jia Fan
Fudan University
1 shared publication - Jian Lin
Fudan University 2 Shanghai
1 shared publication
Latest Publications
- Top Cited Papers
- 3 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6695) , eadj4857
A blueprint for tumor-infiltrating B cells across human cancers
B lymphocytes are essential mediators of humoral immunity and play multiple roles in human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell blueprint encompassing single-cell transcriptome, B cell–receptor repertoire, and chromatin accessibility data across 20 different cancer types (477 samples, 269 patients). B cells harbored extraordinary heterogeneity and comprised 15 subsets, which could be grouped into two independent developmental paths (extrafollicular versus germinal center). Tumor types grouped into the extrafollicular pathway were linked with worse clinical outcomes and resistance to immunotherapy. The dysfunctional extrafollicular program was associated with glutamine-derived metabolites through epigenetic-metabolic cross-talk, which promoted a T cell–driven immunosuppressive program. These data suggest an intratumor B cell balance between extrafollicular and germinal-center responses and suggest that humoral immunity could possibly be harnessed for B cell–targeting immunotherapy.
- 3 May 2024
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 384 (6695) , eadj4857
Top Cited PapersA blueprint for tumor-infiltrating B cells across human cancers
B lymphocytes are essential mediators of humoral immunity and play multiple roles in human cancer. To decode the functions of tumor-infiltrating B cells, we generated a B cell blueprint encompassing single-cell transcriptome, B cell–receptor repertoire, and chromatin accessibility data across 20 different cancer types (477 samples, 269 patients). B cells harbored extraordinary heterogeneity and comprised 15 subsets, which could be grouped into two independent developmental paths (extrafollicular versus germinal center). Tumor types grouped into the extrafollicular pathway were linked with worse clinical outcomes and resistance to immunotherapy. The dysfunctional extrafollicular program was associated with glutamine-derived metabolites through epigenetic-metabolic cross-talk, which promoted a T cell–driven immunosuppressive program. These data suggest an intratumor B cell balance between extrafollicular and germinal-center responses and suggest that humoral immunity could possibly be harnessed for B cell–targeting immunotherapy.